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ABSTRACT
Aim: A previous maternal and infant nutrition intervention in rural Matlab, Bangladesh,
showed that prenatal nutrient supplements improved child survival, but had no effect on
size at birth. This secondary analysis examined whether prenatal multiple micronutrient
supplements (MMS), on their own or combined with an early invitation to receive prenatal
food supplements, affected child morbidity.
Methods: This randomised trial enrolled 4436 pregnant women from November 2001 to
October 2003 and allocated them to early or standard invitations to food supplements, in
the ninth and 20th weeks of pregnancy, respectively, and supplements of either the
standard 60 mg iron with 400 lg folic acid, 30 mg iron with 400 lg folic acid or MMS.
Quasi-Poisson regression was used to analyse morbidity.
Results: There were 3560 single live births and 3516 had morbidity data. The incidence
rates of fever, diarrhoea and acute lower respiratory tract infection were 15.3, 3.6 and 2.3
episodes per person-year, respectively. The separate or combined interventions had no
effect on morbidity up to 24 months.
Conclusion: Early invitations to prenatal food supplements or prenatal MMS had no effect
on common infections in rural Bangladesh, suggesting that earlier findings on improved
child survival were not mediated by an effect on child morbidity.
BACKGROUND
The nutritional status of women before and during preg-
nancy is critical for foetal and child growth and survival (1).
Iron deficiency anaemia in pregnancy increases the risk of
poor pregnancy outcomes (1), and the World Health
Organization has recommended iron folic acid supplements
for all pregnant women for several decades and continues
to do so (2). Many pregnant women living in poor settings
are also deficient in macronutrients and other micronutri-
ents in addition to iron (1). Prenatal multiple micronutrient
supplements (MMS) were developed for trial purposes for
settings with co-existing micronutrient deficiencies (3).
Compared to iron supplements, with or without folic acid,
pooled analyses have shown that prenatal MMS have a
small favourable effect on the risk of stillbirths, low birth
weight and being small-for-gestational age, but have no
effect on neonatal mortality (4). Possible health effects
beyond the foetal period have not been studied so fre-
quently. Food supplements during pregnancy have lowered
the risk of stillbirths and increased foetal growth, especially
among undernourished mothers (5). Data on the timing of
prenatal food supplements are scarce, but evidence from
famine studies and animal studies suggests that nutritional
deficiencies at different time points in pregnancy have
different effects on the offspring later on (6,7).
Abbreviations
ALRI, Acute lower respiratory tract infection; CI, Confidence
interval; Fe30FA, Micronutrient supplement with 30 mg iron and
400 lg folic acid; Fe60FA, Micronutrient supplement with 60 mg
iron and 400 lg folic acid; icddr,b, International Centre for
Diarrhoeal Diseases Research, Bangladesh; MINIMat trial,
Maternal and infant nutrition interventions in Matlab trial;
MMS, Multiple micronutrient supplements; OR, Odds ratio;
RR, Relative risk; SD, Standard deviation.
Key notes
 We have previously shown that an early invitation to
receive earlier prenatal food supplements and prenatal
multiple micronutrients improved child mortality.
 This secondary analysis focused on morbidity rates of
3516 children and showed that these interventions,
separately or combined, were not associated with the
incidence of common early childhood infections.
 The results suggest that the earlier effects on mortality
were not mediated by an effect on child morbidity.
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Bangladesh is a low-income country where co-existing
nutrient deficiencies are common among pregnant women
and children (8,9) with almost one-quarter of children
being born with a low birth weight (10). The Maternal and
Infant Nutrition Interventions in Matlab (MINIMat) trial
was a randomised community-based trial in rural Bangla-
desh. It studied the effect of the timing of early versus
standard invitation to receive prenatal food supplements
and the type of micronutrient supplementation, namely iron
folic acid versus MMS or a combination of these, on birth
weight, infant survival and maternal haemoglobin status.
Early invitations to receive food supplements or MMS had
no differential effect on birth weight or maternal haemo-
globin status. However, MMS combined with an early
invitation to receive food supplements resulted in a
considerable reduction in mortality in infants and children
under five compared to standard iron folic acid supple-
ments with the standard invitation to receive food supple-
ments (11). The interventions also had effects on child
growth, early prenatal food supplements lowered the
occurrence of stunting, while MMS increased stunting in
children up to five years of age (12).
Morbidity from common infections could act as a
mediator that affects growth and mortality. Only a few
trials have previously studied the effects of prenatal MMS
on child morbidity. In trials in Nepal, prenatal MMS had no
effect on child morbidity in the first weeks of life when
compared to prenatal vitamin A supplements (13) or at a
mean age of 2.5 years when compared to iron folic acid
supplements (14). A trial among women with the human
immunodeficiency virus infection in Tanzania found that
prenatal multivitamin supplements lowered the risk of
diarrhoea in children (15). No studies that we know of
have analysed the effect of the timing of prenatal food
supplements or the effect of the timing of prenatal food
supplements combined with multiple micronutrients on
child morbidity.
This study analyses the effects of prenatal food and
micronutrient interventions on child morbidity, which was
one of the secondary outcomes of the MINIMat trial. We
hypothesised that early timing of prenatal food supplements
and prenatal MMS, separately or in combination, would
have a favourable effect on morbidity in children up to
24 months of age in rural Bangladesh, compared to the
standard timing of food supplements and the standard iron
folic acid supplements.
METHODS
Study setting and participants
The MINIMat trial was set in Matlab, a rural subdistrict in
Bangladesh, where a well-established health and demo-
graphic surveillance system is run by the International
Centre for Diarrhoeal Disease Research, Bangladesh (icddr,
b). If a woman reported having missed her menstrual period
or suspected she was pregnant during a monthly surveil-
lance system data collection, she was offered a pregnancy
test and an ultrasound examination. When a pregnancy
with a viable foetus of less than 14 weeks of gestation was
confirmed, women without severe illness were invited to
participate in the trial. Twins were excluded from follow-up
studies after birth, as their expected differences to single-
tons, with regard to gestational age and size at birth, could
influence their later development. For this analysis, all
singleton children with data on morbidity were included.
Study design and interventions
The trial had a 2 9 3 factorial design with two food groups
and three micronutrient groups, resulting in a total of six
groups. At the time of the trial, the Government provided
pregnant women with food supplements and the women
typically chose to start taking these around 20 weeks of
gestation. For the trial, the participants were randomised to
receive either the standard invitation to food supplements
or were invited to start them as soon as their pregnancy was
confirmed around nine weeks of gestation. The supplement
was available in community nutrition centres six days a
week. It contained 608 calories and 18 g of protein from
roasted rice powder (80 g), roasted pulse powder (40 g),
molasses (20 g) and soya bean oil (12 mL). The women
were also randomised to receive one of these three daily
micronutrient supplements starting from 14 weeks of ges-
tation: (i) 60 mg iron fumarate with 400 lg folic acid
(Fe60FA, which was standard in this area for all pregnant
women), (ii) 30 mg iron fumarate with 400 lg folic acid
(Fe30FA) or (iii) MMS containing 30 mg iron fumarate,
400 lg folic acid, 800 lg RE vitamin A, 200 IU vitamin D,
10 mg vitamin E, 70 mg vitamin C, 1.4 mg vitamin B1,
1.4 mg vitamin B2, 18 mg niacin, 1.9 mg vitamin B6, 2.6 lg
vitamin B12, 15 mg zinc, 2 mg copper, 65 lg selenium and
150 lg iodine (3). The women received a new bottle of
micronutrient capsules monthly. More details of the trial
have previously been published (11).
Data collection and outcomes
Trained field workers collected the data using structured
questionnaires. Information on maternal age, parity, height,
weight, education and household assets was obtained at
enrolment, and household assets were analysed to create a
score index (16).
The newborn infants were examined at home one week
after the birth by a field worker who collected data on the
following signs of illness: lethargy or unconsciousness,
bulging fontanel, grunting, chest indrawing, fever or unusu-
ally cold skin, skin pustules, purulent eye discharge, red or
purulent umbilicus and jaundice, defined as yellow colour-
ing in the palms or soles. The respiratory rate was measured,
and the child was considered to have rapid breathing if two
consecutive measurements were at least 60 breaths per
minute (17). The mother was also asked whether the
newborn infant had experienced convulsions or difficulties
breathing. Newborn morbidity was categorised as any signs
of illness. Local infections were defined as having skin
pustules, purulent eye discharge and/or red or purulent
umbilicus, while severe illness was defined as convulsions,
lethargy or unconsciousness, chest indrawing, bulging
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fontanel, grunting and/or rapid breathing (18). If a child
had more than one missing value on the signs of illness in
any of the newborn morbidity categories, they were
considered to have a missing value on that outcome
category.
To assess the morbidity of the children up to 24 months
of age, the field workers conducted monthly visits for the
first year and quarterly visits in the second year, making
16 visits in total. During these visits, they asked the
mother whether the child had had a fever, diarrhoea,
cough or difficult breathing during the last seven days. If
the mother reported a cough or difficult breathing, she
was asked about the presence of rapid breathing or chest
indrawing. Acute lower respiratory tract infection (ALRI)
was defined as the presence of a cough and/or difficult
breathing with rapid breathing and/or chest indrawing
(17). Diarrhoea was defined as at least three loose stools
in 24 hours and the mothers were asked about whether
there was any blood in the stools during diarrhoea. The
outcomes analysed for morbidity in children of 1–
24 months of age were diarrhoea, diarrhoea with blood,
fever and ALRI. The presence of morbidity during the
seven-day recall period was considered as one episode
regardless of its duration.
Sample size and randomisation
The sample size calculation for the trial was based on the
primary aim of detecting a difference of 70 g in birth weight,
which was considered as the minimum clinically important
difference. A standard deviation (SD) of 400 g was assumed
in the calculations. Further details have previously been
reported (11). The amount of person-time in the current
analyses allowed for the detection of a difference in the
incidence of diarrhoea of 0.35 between the food groups,
using the standard timing of supplements as the reference,
and 0.41 between the micronutrient groups, using Fe60FA
as reference. It also allowed for a 0.28 difference in the
incidence of ALRI between the food groups and 0.33
between the micronutrient groups for children of 1–
24 months of age.
An independent statistician used a computer-based reg-
ister to randomly allocate participants to one of the six
intervention groups in permuted blocks of 12 and the
randomisation codes were kept safe in the icddr,b admin-
istrative office. The participants and data collectors were
blinded for the micronutrient supplementation and the
micronutrient capsules looked identical and came in iden-
tical bottles.
Statistical analysis
For the baseline characteristics, a mean with SD was
calculated for continuous variables and proportions were
calculated for categorical variables. To test for differences in
the baseline characteristics between the mothers included
in the analysis and the ones lost to follow-up, Pearson’s chi-
square test was performed for categorical variables and
Welch’s two-sample t-test was used for continuous
variables.
The prevalence rates of the signs of newborn illness were
calculated as percentages of the total sample and the
intervention groups. Logistic regression was used to calcu-
late the odds ratios (OR) of having any signs of illness, local
infections and severe illness as binary yes/no outcomes, in
the food groups with standard supplement timing as the
reference and micronutrient groups with Fe60FA as the
reference. An interaction between the main effects was
tested by adding an interaction term to the regression model
(food*micronutrient).
For the morbidity analysis of children of 1–24 months of
age, the incidence rate of illness was calculated as the mean
number of episodes of illness per person-year, with 95%
confidence intervals (95% CI) in the total sample and the
food and micronutrient groups. A quasi-Poisson regression
was used to calculate and compare the relative risks (RR) of
morbidity across the different intervention groups, with the
incidence as the dependent variable and the food and
micronutrient groups as the independent variables, again
using the standard timing of supplements and Fe60FA as
references, respectively. A quasi-Poisson regression was
used instead of a Poisson regression to adjust for overdis-
persion (19). The interaction between the interventions was
tested in the same way as described earlier. When an
interaction was detected, the effect estimate (RR) of the
combination showing a significant interaction was calcu-
lated and evaluated.
A two-sided p-value of <0.05 was considered statistically
significant and 95% CI was used in all the analyses.
Statistical analyses were conducted using R version 3.1.1
(R Core Team, Vienna, Austria) with package R Comman-
der (20).
Ethical considerations
The Research and Ethics Review Committees of icddr,b
approved the trial protocol, and the trial was registered in
the International Standard Randomised Control Trial
Number database (ISRCTN16581394). Informed consent
was obtained from all women who participated at enrol-
ment and they were told that they could withdraw from the
trial, or any component of the trial, at any time without it
affecting their free health care. Pregnant women with severe
anaemia were excluded from the trial and referred for
further care. Continuous monitoring for adverse effects was
carried out and the field workers advised participants to
seek health care if they developed a severe illness.
RESULTS
Between November 2001 and October 2003, a total of 4436
women were randomised to receive one of the six combi-
nations of food and micronutrient supplements (Fig. 1), but
845 women were lost to follow-up, mainly due to pregnancy
loss, moving out of the area or because they withdrew their
consent. The remaining 3591 women gave birth to 3625
babies between April 2002 and June 2004. After birth, 65
twin children were excluded from the growth and morbidity
data collection and 44 children were lost to follow-up,
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which meant that we had morbidity data on 3516 singleton
children. Overall, the losses in the morbidity follow-up were
small, but they were especially small in the group that was
allocated to an early invitation to food supplements com-
bined with multiple micronutrients, which had the lowest
number of neonatal deaths (11). Data on signs of illness
seven days after birth were available for 2186 newborn
infants. The local tradition of visiting family around the time
of the birth reduced the number of follow-ups. The baseline
characteristics of those with data on neonatal illness did not
differ from those without such data.
The baseline characteristics were similar across the six
intervention groups (Table 1). The mean maternal height
was 149.8 cm (SD 5.3), the mean weight was 45.3 kg (SD
6.8) and 28.0% of mothers were underweight, with a body
mass index of less than 18.5 at enrolment. The mothers had
an average of 5.2 years (SD 4.1) of education. The median
number of follow-up visits was 16 in all of the intervention
groups, ranging from one to 16 visits with 90% having at
least 11 visits. This resulted in a total of 966 (90%) of 1079
possible person-years of observation.
Overall, one-fifth of all newborns had any signs of illness
at the follow-up visits seven days after birth (Table S1). The
most common signs of illness were jaundice (9.5% preva-
lence), red or purulent umbilicus (4.5%) and skin pustules
(4.4%). No association was found between the timing of
food supplements or type of micronutrient supplements, or
a combination of these, and signs of illness in the newborn
infant.
The most commonly reported symptom of an illness
among children of 1–24 months of age was fever, with an
average of 15.3 episodes per person-year. The timing of food
supplements and type of micronutrient supplements, sepa-
rately or in combination, did not have an effect on fever
(Table 2). The incidence of diarrhoea was 3.6 episodes per
person-year. Early food supplementation (versus standard)
or MMS (versus Fe60FA), or a combination of these, were
not found to have an effect on diarrhoea morbidity.
However, Fe30FA (versus Fe60FA) was found to increase
the risk of diarrhoea (3.91 versus 3.40 episodes per person-
year, RR 1.66, 95% CI 1.16–2.38). A significant statistical
interaction between the early food group and Fe30FA was
detected, and early food plus Fe30FA (versus standard food
plus Fe60FA) showed a significantly increased risk of
diarrhoea (RR 1.87, 95% CI 1.11–3.16). The incidence of
episodes of the more severe form of diarrhoea with blood in
the stools was 0.24 per person-year. We found no differ-
ences between the food or micronutrient groups. A signif-
icant statistical interaction between the early food group
and Fe30FA and between the early food group and MMS
5880 women assessed for eligibility
1444 excluded:
603 gestational age 14 weeks
217 no viable foetus
504 refused
112 migrated
8 other reasons
4436 randomised
Early food + Fe60FA
738 randomised
738 received MN
Early food +Fe30FA
739 randomised
739 received MN
Early food + MMS
740 randomised
740 received MN
Standard food + Fe60FA
738 randomised
738 received MN
Standard food + Fe30FA
741 randomised
741 received MN
Standard food + MMS
740 randomised
740 received MN
134 lost to follow-up:
13 abortion
39 spontaneous abortion
16 stillbirth, single
17 withdrew consent
33 migrated
1 maternal death
15 other reasons
137 lost to follow-up:
19 abortion
45 spontaneous abortion
13 stillbirth, single
26 withdrew consent
21 migrated
0 maternal death
13 other reason
149 lost to follow-up:
23 abortion
33 spontaneous abortion
18 stillbirth, single
20 withdrew consent
39 migrated
0 maternal death
16 other reasons
130 lost to follow-up:
22 abortion
31 spontaneous abortion
15 stillbirth, single
18 withdrew consent
30 migrated
0 maternal death
14 other reasons
143 lost to follow-up:
19 abortion
38 spontaneous abortion
18 stillbirth, single
24 withdrew consent
30 migrated
0 maternal death
14 other reasons
152 lost to follow-up:
15 abortion
50 spontaneous abortion
9 stillbirth, single
24 withdrew consent
35 migrated
0 maternal death
19 other reasons
604 women gave birth to
610 live babies, but
11 twins were excluded
(stillbirths were excluded)
602 women gave birth to 
608 live babies, but
11 twins were excluded
(stillbirths were excluded)
591 women gave birth to
595 live babies, but
8 twins were excluded
(stillbirths were excluded)
608 women gave birth to
612 live babies, but
8 twins were excluded
(stillbirths were excluded)
598 women gave birth to
605 live babies, but
13 twins were excluded
(stillbirths were excluded)
588 women gave birth to
595 live babies, but
14 twins were excluded
(stillbirths were excluded)
599 single live births 597 single live births 587 single live births 604 single live births 592 single live births 581 single live births
10 missing morbidity 
information
7 missing morbidity 
information
1 missing morbidity 
information
14 missing morbidity 
information
3 missing morbidity 
information
9 missing morbidity 
information
589 children with any data on 
morbidity 1–24 months and 
included in main analysis 
590 children with any data on 
morbidity 1–24 months and 
included in main analysis
586 children with any data on 
morbidity 1–24 months and 
included in main analysis
590 children with any data on 
morbidity 1–24 months and 
included in main analysis
589 children with any data on 
morbidity 1–24 months and 
included in main analysis
572 children with any data on 
morbidity 1–24 months and 
included in main analysis
Early: Early invitation to food supplementation (around week 9 of gestation); standard: standard timing of invitation to food supplementation (around week 20 of gestation); Fe60FA: 60 mg of iron and 400 µg folic acid;
Fe30FA: 30 mg of iron and 400 µg folic acid; MMS: multiple micronutrient supplementation including 30 mg iron and 400 µg folic acid and 13 other micronutrients; MN: micronutrient
Figure 1 Study flow.
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was detected for diarrhoea with blood. Early food plus
Fe30FA (versus standard food plus Fe60FA) showed a
decreased risk of diarrhoea with blood (RR 0.88, 95% CI
0.77–0.99). The effect estimate of early food plus MMS
(versus standard food plus Fe60FA) was, however, not
statistically significant (RR 0.91, 95% CI 0.80–1.04). The
incidence of ALRI was 2.3 episodes per person-year. The
interventions, separately or combined, were not found to
have an effect on the incidence of ALRI.
DISCUSSION
We have shown that in a population in Bangladesh where
malnourishment was common, an early invitation to receive
prenatal food supplements or MMS, or a combination of
these, had no association with newborn morbidity and did
not reduce the incidence of fever, diarrhoea or ALRI in
children of 1–24 months of age. This was despite a previ-
ously reported reduction in neonatal and infant mortality in
children born to mothers allocated to an early invitation to
food supplements combined with MMS (11).
The results were based on a community-based trial,
conducted in an area with a well-established health and
demographic surveillance system that enabled early identi-
fication of pregnancy. Community members were accus-
tomed to, and compliant with, study activities linked to
service provision, which strengthened the quality of the
data. The randomised design minimised the risk of potential
confounding and double masking of the micronutrient
intervention reduced the risk of reporting or observation
bias. All analyses were carried out according to the original
randomisation regardless of adherence, thus reflecting the
true, unbiased effect of the intervention. We had a relatively
large sample size and regular data collection, 99% of the
singleton children were included in the morbidity follow-
up, and we achieved 90% of the possible person-years of
follow-up. The data on morbidity being reported by the
infants’ carers was a limitation and this could have over- or
underestimated the incidence rates. A recall period of seven
days, which has been found to be the optimal recall time
with this kind of reported data, was used to minimise recall
bias (21).
We have previously shown that an early invitation to
receive prenatal food supplements combined with prenatal
MMS, compared to the standard invitation to receive food
supplements and standard iron folic acid supplements,
lowered the infant mortality rate (16.8 per 1000 live births
versus 44.1 per 1000 live births, hazard ratio 0.38, 95% CI
0.18–0.78) (11). The early invitation to receive food
supplements with MMS seemed to have influenced foetal
and infant health without having differential effects on size
at birth. In a substudy, the thymic volume was assessed by
ultrasound at eight, 24 and 52 weeks of age, showing that
the prenatal supplements did not affect thymic size (22).
Thymic size in early infancy was associated with subsequent
survival (23). The associations between supplements and
child growth were more complex. The early invitation to
receive food supplements in pregnancy reduced theT
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occurrence of stunting in children 0–54 months of age,
while prenatal MMS increased stunting. These effects were
judged to be of public health importance and could indicate
programming in early foetal life (12). Our hypothesis in this
paper relates to these previous findings, which showed that
MINIMat prenatal interventions had effects on child
growth and mortality (11,12). An effect on morbidity, if
present, could potentially mediate part of the effects on
mortality and growth. However, such a mediating role did
not seem to be present.
In a prenatal supplement trial in Nepal with different
micronutrient alternatives, MMS with a slightly different
composition were found to have no effect on infectious
disease symptoms in the first 10 days of life or in seven or
Table 2 Incidence of reported morbidity among children aged 1–24 months in the supplement groups in the MINIMat trial in rural Bangladesh
Morbidity, interventions n Person-years Incidence* (95% CI) RR† (95% CI) p Value‡
Diarrhoea
Total 3516 965.81 3.64 (3.49–3.78)
Food
Standard 1751 477.94 3.58 (3.38–3.79) 1.00
Early 1765 487.87 3.69 (3.47–3.92) 1.12 (0.84–1.51)
Micronutrient
Fe60FA 1179 325.57 3.40 (3.15–3.64) 1.00
Fe30FA 1179 322.58 3.91 (3.65–4.17) 1.66 (1.16–2.38)
MMS 1158 317.67 3.60 (3.36–3.87) 1.22 (0.86–1.74)
Early 9 Fe30FA 0.041
Early 9 MMS 0.317
Diarrhoea with blood
Total 3516 965.81 0.24 (0.20–0.27)
Food
Standard 1751 477.94 0.27 (0.23–0.32) 1.00
Early 1765 487.87 0.20 (0.16–0.25) 0.93 (0.87–1.00)
Micronutrient
Fe60FA 1179 325.57 0.24 (0.19–0.30) 1.00
Fe30FA 1179 322.58 0.23 (0.18–0.30) 0.99 (0.92–1.08)
MMS 1158 317.67 0.24 (0.18–0.30) 0.99 (0.92–1.08)
Early 9 Fe30FA 0.029
Early 9 MMS 0.002
Fever
Total 3516 965.81 15.31 (14.98–15.61)
Food
Standard 1751 477.94 15.14 (14.69–15.57) 1.00
Early 1765 487.87 15.47 (15.01–15.92) 1.40 (0.75–2.60)
Micronutrient
Fe60FA 1179 325.57 15.21 (14.66–15.75) 1.00
Fe30FA 1179 322.58 15.59 (15.03–16.14) 1.46 (0.68–3.14)
MMS 1158 317.67 15.12 (14.61–15.63) 0.92 (0.43–1.96)
Early 9 Fe30FA 0.314
Early 9 MMS 0.365
Acute lower respiratory tract infection
Total 3516 965.81 2.33 (2.20–2.48)
Food
Standard 1751 477.94 2.33 (2.13–2.55) 1.00
Early 1765 487.87 2.34 (2.14–2.54) 1.01 (0.76–1.34)
Micronutrient
Fe60FA 1179 325.57 2.25 (2.02–2.51) 1.00
Fe30FA 1179 322.58 2.56 (2.30–2.83) 1.37 (0.97–1.95)
MMS 1158 317.67 2.18 (1.92–2.43) 0.93 (0.67–1.31)
Early 9 Fe30FA 0.640
Early 9 MMS 0.481
Fe60FA = 60 mg of iron and 400 lg folic acid; Fe30FA = 30 mg of iron and 400 lg folic acid; MMS = Multiple micronutrient supplementation including 30 mg
iron and 400 lg folic acid and 13 other micronutrients.
*Episodes per person-year.
†Relative risk estimated with quasi-Poisson regression, food or micronutrient intervention as predictor, morbidity as outcome.
‡Interaction between main effects, standard and Fe60FA as references.
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30 days preceding a follow-up at six weeks of life (13). The
prevalence of different signs of illness, assessed mainly
through maternal recall, was higher in the Nepali study
than in ours, suggesting that our estimates of newborn
infectious disease morbidity were low.
Themicronutrient supplement alternativewith 30 mg iron
with 400 lg folic acid (Fe30FA) was included in this trial
mainly in relation to the maternal haemoglobin outcome in
the third trimester. In the present analysis, we noted a slightly
higher incidence of diarrhoea in the Fe30FA group than in
the group receivingFe60FA.The absolute differencewas0.56
episodes per person-year, implying somewhat limited public
health importance should this finding be true. The mecha-
nismbywhichFe30FAwould increase the risk of diarrhoea is
unclear. We have previously reported that no differences
were found between the Fe60FA and Fe30FA groups at six
months of age with regard to anaemia or deficiencies in iron,
zinc, vitamin B12 or folate (24).
The incidence of diarrhoea in our study was 3.6 episodes
per person-year, which was similar to the level of 4.25
episodes per person-year reported by another study con-
ducted in rural Bangladesh (25). We did not find that MMS
had any effect on diarrhoea morbidity. A trial in Tanzania
found a 14% lowered risk of diarrhoea among children aged
six weeks to two years born to mothers infected with the
human immunodeficiency virus who had received micronu-
trient supplements with nine different vitamins during
pregnancy (15). Some studies have reported that prenatal
zinc had a protective effect against diarrhoea in infants
(26,27) and low birth weight infants (28). The MMS in our
study contained 15 mg of zinc, which was slightly lower
than the dose used in some other studies (26,28).
The incidence of ALRI in our study was higher than in a
previous study from the same area (29), where field worker
assessments of signs of respiratory illness were used. This
may explain the higher incidence and possible over-
reporting in our study. We did not find any effect on ALRI,
similar to other studies that have investigated the effect of
prenatal micronutrient supplements on respiratory tract
infections (13,15,27,28).
The relationship between morbidity and mortality is
complex. A reduction in mortality does not always mean a
reduction in morbidity, and this was demonstrated in some
earlier vitamin A supplement trials (30). An intervention
may not reduce the incidence of diseases, but it can perhaps
diminish severity and, therefore, reduce the amount of
related deaths.
CONCLUSION
In this trial in rural Bangladesh, we found that an early
invitation to receive prenatal food supplements or prenatal
MMS, or a combination of these, did not reduce the
incidence of fever, diarrhoea or ALRI in infancy and early
childhood. This indicates that the previously reported
effects of nutritional interventions during early pregnancy
on mortality and linear growth were not mediated by
reduced morbidity in infancy and early childhood.
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